These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11166859)

  • 1. High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A.
    Buonaguro L; Buonaguro FM; Tornesello ML; Mantas D; Beth-Giraldo E; Wagner R; Michelson S; Prevost MC; Wolf H; Giraldo G
    Antiviral Res; 2001 Jan; 49(1):35-47. PubMed ID: 11166859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple procedure to generate chimeric Pr55gag virus-like particles expressing the principal neutralization domain of human immunodeficiency virus type 1.
    Brand D; Mallet F; Truong C; Roingeard P; Goudeau A; Barin F
    J Virol Methods; 1995 Feb; 51(2-3):153-68. PubMed ID: 7537750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.
    Wagner R; Deml L; Fliessbach H; Wanner G; Wolf H
    Virology; 1994 Apr; 200(1):162-75. PubMed ID: 7510434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities.
    Tobin GJ; Li GH; Fong SE; Nagashima K; Gonda MA
    Virology; 1997 Sep; 236(2):307-15. PubMed ID: 9325238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K; Forman J; Kräusslich HG; Rose JK
    Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrophilicity dependent budding and secretion of chimeric HIV Gag-V3 virus-like particles.
    Luo L; Li Y; Ha SD; Kang CY
    Virus Genes; 2007 Oct; 35(2):187-93. PubMed ID: 17510784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles.
    Halsey RJ; Tanzer FL; Meyers A; Pillay S; Lynch A; Shephard E; Williamson AL; Rybicki EP
    Virus Res; 2008 May; 133(2):259-68. PubMed ID: 18329748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and characterization of recombinant VLPs and Semliki-Forest virus live vectors for comparative evaluation in the SHIV monkey model.
    Notka F; Stahl-Hennig C; Dittmer U; Wolf H; Wagner R
    Biol Chem; 1999 Mar; 380(3):341-52. PubMed ID: 10223337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 subtype C Gag virus-like particle boost substantially improves the immune response to a subtype C gag DNA vaccine in mice.
    Jaffray A; Shephard E; van Harmelen J; Williamson C; Williamson AL; Rybicki EP
    J Gen Virol; 2004 Feb; 85(Pt 2):409-413. PubMed ID: 14769898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular approaches to AIDS vaccine development using baculovirus expression vectors.
    Kang CY
    Methods Mol Biol; 1995; 39():295-315. PubMed ID: 7542523
    [No Abstract]   [Full Text] [Related]  

  • 13. Chimeric gag-V3 virus-like particles of human immunodeficiency virus induce virus-neutralizing antibodies.
    Luo L; Li Y; Cannon PM; Kim S; Kang CY
    Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10527-31. PubMed ID: 1438241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and immunogenicity of human immunodeficiency virus type 1 Gag expressed by a replication-competent rhabdovirus-based vaccine vector.
    McGettigan JP; Sarma S; Orenstein JM; Pomerantz RJ; Schnell MJ
    J Virol; 2001 Sep; 75(18):8724-32. PubMed ID: 11507217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abrogation of contaminating RNA activity in HIV-1 Gag VLPs.
    Valley-Omar Z; Meyers AE; Shephard EG; Williamson AL; Rybicki EP
    Virol J; 2011 Oct; 8():462. PubMed ID: 21975161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of human immunodeficiency virus genes using baculovirus expression system.
    Kang CY
    Mol Biotechnol; 1997 Oct; 8(2):173-87. PubMed ID: 9406188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prime-boost immunisation regimen using recombinant BCG and Pr55(gag) virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons.
    Chege GK; Thomas R; Shephard EG; Meyers A; Bourn W; Williamson C; Maclean J; Gray CM; Rybicki EP; Williamson AL
    Vaccine; 2009 Jul; 27(35):4857-66. PubMed ID: 19520196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
    Sova P; Volsky DJ; Wang L; Chao W
    J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.